- Rituximab: Uses, Dosage, Side Effects Warnings - Drugs. com
Rituximab is given by IV infusion (an infusion into a vein) by a healthcare provider Rituximab is not chemotherapy, it is a type of immunotherapy called a targeted cancer treatment
- Rituximab - Wikipedia
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells [22] When it binds to this protein it triggers cell death
- 利妥昔单抗注射液（美罗华 Rituximab）说明书-使用指南-医保报销-副作用-是靶向还是免疫？ - 知乎
利妥昔单抗注射液（美罗华 Rituximab）说明书-使用指南-医保报销-副作用-是靶向还是免疫？
- RITUXAN® (rituximab) Medication for RA, NHL, CLL, GPA, MPA PV
Find info for patients about RITUXAN® (rituximab) medication for RA, NHL, CLL, GPA, MPA, and PV See full safety and Boxed Warning for more information
- Rituximab（利妥
药物类型: Rituximab(利妥昔单抗)是一种靶向治疗用药,归类为单克隆抗体。
- Rituximab（美罗华）中文说明书 - 价格 - 功效及副作用详解 - 1健康
什么是Rituximab？ 利妥昔单抗属于一类称为单克隆抗体的药物。 它用于治疗非霍奇金淋巴瘤（NHL）和慢性淋巴细胞白血病（CLL），通过杀死癌细胞发挥作用。
- 認識標靶藥品Rituximab - 衛教單張 - 中國醫藥大學附設醫院
屬抗癌單株抗體藥物，可單獨使用或與其他藥物合併使用於B細胞淋巴瘤，類風溼性關節炎或復發的CD20陽性慢性淋巴性白血病，或依醫師視臨床需求使用。
- Rituximab - PubMed
This activity centers on rituximab, an anti-CD20 monoclonal antibody pivotal in treating various lymphoproliferative and autoimmune disorders The program provides an in-depth exploration of rituximab's indications, mechanisms of action, and crucial aspects of its therapeutic application
|